How to Buy Cytek Biosciences Stock
Cytek Biosciences Inc
Cytek Biosciences, Inc. , a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.
Cytek Biosciences stock last closed at $4.22, up 3.32% from the previous day, and has increased 0% in one year. It has overperformed other stocks in the Medical Devices industry by 0.67 percentage points. Cytek Biosciences stock is currently +78.06% from its 52-week low of $2.37, and -31.72% from its 52-week high of $6.18.
As of Mar 6, 2026, there are 128.55M CTKB shares outstanding. The market capitalization of CTKB is $542.48M. In the past 24 hours, 731,000 CTKB shares were traded.
How to Buy Cytek Biosciences Stock
Wondering how to invest in Cytek Biosciences stock? Here's how.
- Choose where to buy Cytek Biosciences stock: You need to pick an online brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you determine where to buy Cytek Biosciences stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit money your brokerage account: Select your method of payment and add your information.
- Research Cytek Biosciences stock: The Cytek Biosciences ticker symbol is CTKB. Is Cytek Biosciences stock a good investment? Should you buy shares of CTKB? How do CTKB's underlying business fundamentals look? Do top analysts think Cytek Biosciences is a good buy? Why has CTKB's stock price moved recently? (Hint: Our stock market research website can help you decide if CTKB is a good stock to buy).
- Make your CTKB purchase: Decide if you will purchase CTKB shares at the current market price or use a limit order to purchase CTKB shares at a particular price.
- Get the latest scoop on your investment in CTKB: Create a watchlist to monitor your investment in Cytek Biosciences shares.
Step 1: Choose where to buy Cytek Biosciences stock
You will need an online brokerage account in order to access the NASDAQ market and buy CTKB stock.
Our recommended brokerage: eToro
Based on our research, eToro is the best stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world financial markets: From Tech to Healthcare, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've picked your brokerage, you'll need to fill out some personal details so you are able to invest in CTKB stock today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to start a new trading account.
- Submit your data by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you've finished signing up on apps for stock market, you need to deposit funds:
Check out the walkthrough below for more details transferring funds into your investment account.
Step 4: Research Cytek Biosciences stock
After you have figured out the best place to buy Cytek Biosciences stock, it's absolutely critical to analyze their stock prior to buying, so you truly wrap your head around the risk as well as the opportunity.
Cytek Biosciences stock at a glance
Cytek Biosciences Overview
WallStreetZen was created to help part-time investors do more accurate fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on CTKB's stock page.
Is CTKB stock undervalued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge CTKB's intrinsic value.
Using relative valuations metrics:
- CTKB could be undervalued based on its P/B ratio of 1.59x, relative to Medical Devices industry P/B ratio of 3.5x
You can do more valuation analysis on CTKB's stock here.
A quick look at CTKB Financials
Positive Health Checks:
- Total CTKB debt is lower than 5 years ago, relative to shareholder equity.
- CTKB has $261.53M in cash and short term investments. This is enough to cover its annual cash burn of $8.62M.
- There are more short-term assets than long-term liabilities on the CTKB balance sheet.
- CTKB has a low debt to equity ratio of 0.35.
- There are more short-term assets than short-term liabilities on the CTKB balance sheet.
- CTKB has cash burn of 8624000. It has enough cash and short-term investments to cover this for at least one year.
Negative Health Checks:
- CTKB profit margin has gone down from -3% to -33% in the past year.
Is CTKB stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 2 sell side analysts who monitor CTKB, the consensus analyst rating on Cytek Biosciences is a Strong Buy
It's important to note that analyst ratings are not recommendations, nor are they investment advice.
You can dig deeper into what analysts are saying on the Cytek Biosciences stock forecast page.
CTKB Technicals
CTKB Revenue
Last year, CTKB revenue was $201.49M. During the past 5 year, CTKB's revenue has increased by 16.76% per year. This was faster than the Medical Devices industry average of 11.29%.
Dive into CTKB's earnings and revenue performance here.
Are CTKB executives and large shareholders buying or selling the stock?
Over the last year, executives and large shareholders at CTKB have sold more shares than they have bought.
Valerie Barnett, CHIEF LEGAL OFFICER of CTKB, was the latest CTKB insider to sell. They sold $2,205.00 worth of CTKB stock on Feb 18, 2026.
Learn more about who owns CTKB shares here.
Can I rely on CTKB as an income stream?
No, Cytek Biosciences doesn't provide an income stream by paying out dividends.
CTKB Social Trading Data
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Make your CTKB purchase
You have two main options:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are mostly fine. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at an exact dollar amount, place a limit order.
Hit the Open button and eToro will place your order.
If you need additional assistance investing in stocks on eToro, watch the how to video below:
Step 6: Get the latest scoop on your investment in CTKB
Now that you own some CTKB stock, you'll want to stay up-to-date on your company.
Put CTKB on a watchlist to keep tabs on your CTKB stock.
CTKB Feed
How to Buy Stock in Cytek Biosciences
To reiterate, here are the 6 steps to buy stock in Cytek Biosciences:
- Choose where to buy Cytek Biosciences stock
- Sign up for your brokerage account
- Deposit money your brokerage account
- Research Cytek Biosciences stock
- Make your CTKB purchase
- Get the latest scoop on your investment in CTKB
If you require a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get the latest scoop on your new investment in Cytek Biosciences, hit the button below to create your watchlist.
Other Articles You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.